Loading

Please wait...

Bendeka

Generic Name: bendamustine (BEN da MUS teen)
Brand Name: Belrapzo, Bendeka, Treanda
Physician reviewed Bendeka patient information - includes Bendeka description, dosage and directions.
  • Prescription Settings
  • X

Prices and coupons of Bendeka

Set your location
for drug prices near you

Enter your zip code


Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Bendeka is used to treat chronic lymphocytic leukemia. This medicine is also used to treat indolent B-cell non-Hodgkin lymphoma after other medicines have been tried without successful treatment of this condition. Bendeka may also be used for purposes not listed in this medication guide. Tell your caregivers right away if you have any type of skin rash after being treated with Bendeka. You should not be treated with Bendeka if you are allergic to Bendeka, polyethylene glycol, propylene glycol, or Mannitol (Osmitrol). Learn more

Bendeka Side Effects

Bendeka Side Effects

Note: This document contains side effect information about bendamustine. Some of the dosage forms listed on this page may not apply to the brand name Bendeka.

For the Consumer

Applies to bendamustine: intravenous powder for solution, intravenous solution

Along with its needed effects, bendamustine (the active ingredient contained in Bendeka) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking bendamustine:

More common

  • Black, tarry stools
  • bleeding gums
  • blood in the urine or stools
  • chest pain
  • chills
  • cough or hoarseness
  • diarrhea
  • fever
  • headache
  • joint pain, stiffness, or swelling
  • lack or loss of strength
  • lower back, side, or stomach pain
  • muscle aches
  • nausea
  • painful or difficult urination
  • pale skin
  • pinpoint red spots on the skin
  • sore throat
  • stuffy or runny nose
  • swelling of the feet or lower legs
  • swollen glands
  • troubled breathing with exertion
  • ulcers, sores, or white spots in the mouth
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • vomiting

Less common

  • Burning or stinging of the skin
  • fast heartbeat
  • hives, itching, or rash
  • irritation
  • painful cold sores or blisters on the lips, nose, eyes, or genitals
  • redness of the skin
  • stiffness or swelling
  • swelling of the eyelids, face, lips, hands, or feet
  • tightness in the chest
  • troubled breathing or swallowing

Incidence not known

  • Blistering, flaking, or peeling of the skin
  • bluish color
  • changes in skin color
  • dizziness
  • pain, tenderness, or swelling of the foot or leg
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • red skin lesions, often with a purple center
  • red, irritated eyes
  • weakness

Some side effects of bendamustine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Decreased weight

For Healthcare Professionals

Applies to bendamustine: intravenous powder for injection, intravenous solution

Hematologic

Very common (10% or more): Decreased lymphocytes (up to 99%), decreased leukocytes (up to 94%), decreased hemoglobin (up to 89%), decreased neutrophils (up to 86%), decreased platelets (up to 86%), lymphocytopenia (up to 74%), neutropenia (up to 45%), thrombocytopenia (up to 39%), anemia (up to 38%), leukopenia (up to 37%)

Common (1% to 10%): Febrile neutropenia, hemorrhage, lymphopenia

Very rare (less than 0.01%): Hemolysis

Postmarketing reports: Pancytopenia

Gastrointestinal

Very common (10% or more): Nausea (up to 77%), diarrhea (up to 42%), vomiting (up to 40%), constipation (up to 31%), stomatitis (up to 21%), abdominal pain (up to 14%), dyspepsia (up to 14%), gastroesophageal reflux disease (up to 11%)

Common (1% to 10%): Dry mouth, upper abdominal pain, abdominal distension, oral candidiasis

Very rare (less than 0.01%): Gastrointestinal hemorrhage, hemorrhagic esophagitis

Other

Very common (10% or more): Fatigue (up to 64%), infectious episodes (up to 37%), pyrexia (up to 36%), chills (up to 14%), asthenia (up to 13%), herpes zoster (up to 12%), mucosal inflammation

Common (1% to 10%): Pain, infection, herpes simplex, amenorrhea, epididymitis, thirst, cytomegalovirus infection

Uncommon (0.1% to 1%): Sepsis

Very rare (less than 0.01%): Infertility, multi-organ failure

Frequency not reported: Septic shock, general physical health deterioration

Hepatic

Very common (10% or more): Elevated bilirubin (up to 34%), increased creatinine, increased urea

Common (1% to 10%): Increased AST, increased ALT, increased alkaline phosphatase

Frequency not reported: Hepatitis, hepatic failure, gallbladder pain

Metabolic

Very common (10% or more): Anorexia (up to 24%), decreased weight (up to 20%), dehydration (up to 15%), decreased appetite (up to 13%), hypokalemia (up to 11%)

Common (1% to 10%): Hyperuricemia, tumor lysis syndrome, hypomagnesemia

Respiratory

Very common (10% or more): Cough (up to 22%), dyspnea (up to 17%), upper respiratory tract infection (up to 10%), pharyngolaryngeal pain (up to 10%)

Common (1% to 10%): Nasopharyngitis, sinusitis, pneumonia, wheezing, nasal congestion, pulmonary dysfunction

Very rare (less than 0.01%): Pulmonary fibrosis

Frequency not reported: Lung neoplasm, lung infiltration, pleural effusion

Postmarketing reports: Pneumocystis jiroveci pneumonia, pneumonitis

Nervous system

Very common (10% or more): Headache (up to 21%), dizziness (up to 15%), dysgeusia (up to 11%)

Rare (less than 0.1%): Somnolence, aphonia

Very rare (less than 0.01%): Paresthesia, peripheral sensory neuropathy, anticholinergic syndrome, neurological disorders, ataxia, encephalitis

Frequency not reported: Paraplegia, neuralgia

Dermatologic

Very common (10% or more): Rash (up to 16%), erythema (up to 16%), skin allergic reactions (up to 15%)

Common (1% to 10%): Pruritus, dry skin, night sweats, hyperhidrosis, alopecia, skin disorders

Rare (less than 0.1%): Dermatitis, macular-papular rash

Frequency not reported: Toxic skin reactions, bullous exanthema, urticaria

Postmarketing reports: Stevens-Johnson syndrome, toxic epidermal necrolysis

Psychiatric

Very common (10% or more): Insomnia (up to 15%)

Common (1% to 10%): Anxiety, depression

Cardiovascular

Very common (10% or more): Peripheral edema (up to 14%)

Common (1% to 10%): Tachycardia, chest pain, hypotension, cardiac dysfunction (palpitations, angina pectoris, arrhythmia), hypertension

Uncommon (0.1% to 1%): Pericardial effusion

Rare (less than 0.1%): Myocardial infarction, acute circulatory failure, cardiac failure

Very rare (less than 0.01%): Phlebitis

Frequency not reported: Vasculitis

Postmarketing reports: Atrial fibrillation, congestive heart failure

Musculoskeletal

Very common (10% or more): Back pain (up to 14%)

Common (1% to 10%): Arthralgia, extremity pain, bone pain, myalgia

Frequency not reported: Sacral pain

Genitourinary

Very common (10% or more): Urinary tract infection (up to 11%)

Hypersensitivity

Common (1% to 10%): Hypersensitivity reactions

Rare (less than 0.1%): Anaphylaxis, anaphylactoid reaction

Very rare (less than 0.01%): Anaphylactic shock

Local

Common (1% to 10%): Infusion site pain, catheter site pain

Frequency not reported: Extravasation injury, infusion reactions, injection site reactions

Ocular

Frequency not reported: Retinal detachment

Oncologic

Frequency not reported: Pre-malignant and malignant diseases/secondary tumors

Renal

Frequency not reported: Acute renal failure

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.

Source: Drugs.com Bendeka (www.drugs.com/mtm/bendeka.html).